Adverse event associated with a change in nonprescription syringe sale policy

Journal of the American Pharmacists Association

Volumn 50, Issue 5, 2010, Pages 619-622

  Zaller, Nickolas D ^a   Yokell, Michael A ^b,c   Jeronimo, Alexandra ^a,b   Bratberg, Jeffrey P ^d   Case, Patricia ^e   Rich, Josiah D ^a,b  

^a BROWN UNIVERSITY   (United States)

^b MIRIAM HOSPITAL   (United States)

^c BROWN UNIVERSITY   (United States)

^d UNIVERSITY OF RHODE ISLAND   (United States)

^e FENWAY INSTITUTE   (United States)

Author keywords

Bacterial infections; Case report; Injection drug users; Nonprescription syringe sales; OTC products; Pharmacists; Rhode Island

Indexed keywords

ADULT; ARTICLE; ATTITUDE TO HEALTH; CASE REPORT; COMMERCIAL PHENOMENA; DISEASE TRANSMISSION; ECONOMICS; EQUIPMENT; FEMALE; HEALTH PERSONNEL ATTITUDE; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; PENICILLIN RESISTANCE; PHARMACY; POLICY; PRESCRIPTION; STAPHYLOCOCCUS INFECTION; SUBSTANCE ABUSE; SYRINGE;

ADULT; ATTITUDE OF HEALTH PERSONNEL; COMMERCE; EQUIPMENT CONTAMINATION; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEPATITIS C, CHRONIC; HIV INFECTIONS; HUMANS; METHICILLIN RESISTANCE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; PHARMACIES; POLICY; PRESCRIPTIONS; STAPHYLOCOCCAL INFECTIONS; SUBSTANCE ABUSE, INTRAVENOUS; SYRINGES;

EID: 79952798717     PISSN: 15443191     EISSN: 15443450     Source Type: Journal    
DOI: 10.1331/JAPhA.2010.09162     Document Type: Article

References (17)

1. Broadhead RS, van Hulst Y, Heckathorn DD. The impact of a needle exchange's closure. Public Health Rep. 1999;114:439-47.
2. Normand J, Vlahov D, Moses LE. Preventing HIV transmission: the role of sterile needles and bleach. Washington, DC: National Academies Press; 1995.
3. Rich J, Strong L, Mehrotra M, Macalino G. Strategies to optimize the impact of needle exchange programs. AIDS Read. 2000;10:421-9.
4. Battles HB, Rowe KA, Ortega-Peluso C, et al. Who purchases nonprescription syringes? Characterizing customers of the Expanded Syringe Access Program (ESAP). J Urban Health. 2009;86:946-50.
5. Holtgrave DR, Pinkerton SD, Jones TS, et al. Cost and cost-effectiveness of increasing access to sterile syringes and needles as an HIV prevention intervention in the United States. J Acquir Immune Defic Syndr Hum Retrovirol. 1998;18(suppl 1):S133-8.
6. Laufer FN. Cost-effectiveness of syringe exchange as an HIV prevention strategy. J Acquir Immune Defic Syndr. 2001;28:273-8.
7. Des Jarlais DC, Perlis T, Arasteh K, et al. HIV incidence among injection drug users in New York City, 1990 to 2002: use of serologic test algorithm to assess expansion of HIV prevention services. Am J Public Health. 2005;95:1439-44.
8. Watters JK, Estilo MJ, Clark GL, Lorvick J. Syringe and needle exchange as HIV/AIDS prevention for injection drug users. JAMA. 1994;271:115-20.
9. Rhode Island Department of Health. Rules and regulations governing hypodermic needles, syringes and other such instruments. R21-28-CS-4. Providence, RI: Rhode Island Department of Health; 2002:4.
10. Singer M, Baer HA, Scott G, et al. Pharmacy access to syringes among injecting drug users: follow-up findings from Hartford, Connecticut. Public Health Rep. 1998;113(suppl 1):81-9.
11. Tesoriero JM, Battles HB, Klein SJ, et al. Expanding access to sterile syringes through pharmacies: assessment of New York's Expanded Syringe Access Program. J Am Pharm Assoc. 2009;49:407-16.
12. Rich J, Martin E, Macalino G, et al. Pharmacist support for selling syringes without a prescription to injection drug users in Rhode Island. J Am Pharm Assoc. 2002;42(6 suppl 2):S58-61.
13. Lewis BA, Koester SK, Bush TW. Pharmacists' attitudes and concerns regarding syringe sales to injection drug users in Denver, Colorado. J Am Pharm Assoc. 2002;42(6 suppl 2):S46-51.
14. Blumenthal WJ, Springer KW, Jones TS, Sterk CE. Pharmacy student knowledge, attitudes, and beliefs about selling syringes to injection drug users. J Am Pharm Assoc. 2002;42(6 suppl 2):S34-9.
15. Des Jarlais DC, McKnight C, Goldblatt C, Purchase D. Doing harm reduction better: syringe exchange in the United States. Addiction. 2009;104:1441-6.
16. Dwyer R, Topp L, Maher L, et al. Prevalences and correlates of non-viral injecting-related injuries and diseases in a convenience sample of Australian injecting drug users. Drug Alcohol Depend. 2009;100:9-16.
17. Saravolatz LD, Markowitz N, Arking L, et al. Methicillin-resistant Staphylococcus aureus: epidemiologic observations during a community-acquired outbreak. Ann Intern Med. 1982;96:11-6.